For instance, in LSCC we observed four TFs (HOXA4, HOXA5, TAL1, ZNF132) undergoing promoter hypermethylation in at least 50 % of the LSCC tumour samples where these TFs were underexpressed. This evidence concerns the gene TAL1 and neoplasm.